Subscribe to RSS
DOI: 10.1055/s-2008-1017499
© Georg Thieme Verlag KG Stuttgart · New York
Nadelfreie Konnektionsventile und Blutstrominfektionen - Kommentar aus klinischer Sicht
Needleless connection valves - commentary from a clinical perspectivePublication History
eingereicht: 29.5.2007
akzeptiert: 11.10.2007
Publication Date:
23 January 2008 (online)

Zusammenfassung
Nadelfreie Konnektionsventile (NFCs) für Infusionssysteme bzw. für die Blutentnahme aus dem zentralvenösen Katheter oder für die Bolusapplikation von Medikamenten können für die Patienten und das Personal von Vorteil sein. In der Literatur gibt es jedoch eine Reihe von Berichten zu einer erhöhten Rate Katheter-assoziierter Infektionen nach Neueinführung von NFCs. Wenn in vitro Studien die Sicherheit des NFC belegen (Desinfizierbarkeit der Membran, keine internen Kontaminations- Reservoire im Gebrauch) und ihre Neueinführung von einer kontinuierlichen Surveillance Katheter-assoziierter Infektionen begleitet wird, können bestimmte NFC im klinischen Alltag wahrscheinlich die Sicherheit und die Praktikabilität der intravenösen Therapie über zentralvenöse Katheter für Patient und Behandlungsteam erhöhen.
Abstract
Needle-less connection valves (NFCs) for infusion systems, blood drawing- or i. v. injection ports may offer significant benefits to the patient and the attending health care workers. On the other hand, a number of recent reports described a relationship between an increased incidence density of catheter-associated infections and the introduction of certain NFCs in clinical practice. Thus, the safety of the device in terms of an effective and feasible disinfection protocol for the outer membrane and absence of unintended bacterial deposits inside the device should have been confirmed with appropriate in vitro investigations. In addition, the introduction into clinical practice should be supervised by continuously performed surveillance for catheter-associated infections. Taking these prerequisites into account, NFCs may increase the safety and feasibility of intravenous therapy using central venous catheters in high-risk patients.
Schlüsselwörter
Konnektionsventile - iv. Katheter-Bakteriämie
Key words
valve connectors - iv. catheter bloodstream infection
Literatur
- 1
Adams D, Karpanen T, Worthington T, Lambert P, Elliott T S.
Infection risk associated with a closed luer access device.
J Hosp Infect.
2006;
62
353-7
Reference Ris Wihthout Link
- 2
Arduino M J, Bland L A, Danzig L E, McAllister S K, Aguero S M.
Microbiologic evaluation of needleless and needle-access devices.
Am J Infect Control.
1997;
25
377-80
Reference Ris Wihthout Link
- 3
Bouza E, Munoz P, Lopez-Rodriguez J. et al .
A needleless closed system device (CLAVE) protects from intravascular catheter tip
and hub colonization: a prospective randomized study.
J Hosp Infect.
2003;
54
279-87
Reference Ris Wihthout Link
- 4
Brown M.
The impact of safety product use on catheter-related infections.
J Infus Nurs.
2004;
27
245-50
Reference Ris Wihthout Link
- 5
Casey A L, Lambert P A and Elliott TS.
Is there evidence for recommending needleless closed catheter access systems in guidelines?.
J Hosp Infect.
2006;
64
405-6
Reference Ris Wihthout Link
- 6
Casey A L, Worthington T, Lambert P A. et al .
A randomized, prospective clinical trial to assess the potential infection risk associated
with the PosiFlow needleless connector.
J Hosp Infect.
2003;
54
288-93
Reference Ris Wihthout Link
- 7
Cesaro S, Cavaliere M, Spiller M. et al .
A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using
a CLC 2000 connector device.
Support Care Cancer.
2007;
15
95-9
Reference Ris Wihthout Link
- 8
Cookson S T, Ihrig M, O’Mara E M. et al .
Increased bloodstream infection rates in surgical patients associated with variation
from recommended use and care following implementation of a needleless device.
Infect Control Hosp Epidemiol.
1998;
19
23-7
Reference Ris Wihthout Link
- 9
Danzig L E, Short L J, Collins K. et al .
Bloodstream infections associated with a needleless intravenous infusion system in
patients receiving home infusion therapy.
Jama.
1995;
273
1862-4
Reference Ris Wihthout Link
- 10
Do A N, Ray B J, Banerjee S N. et al .
Bloodstream infection associated with needleless device use and the importance of
infection-control practices in the home health care setting.
J Infect Dis.
1999;
179
442-8
Reference Ris Wihthout Link
- 11
Donlan R M, Murga R, Bell M. et al .
Protocol for detection of biofilms on needleless connectors attached to central venous
catheters.
J Clin Microbiol.
2001;
39
750-3
Reference Ris Wihthout Link
- 12
Field K, McFarlane C, Cheng A C. et al .
Incidence of catheter-related bloodstream infection among patients with a needleless,
mechanical valve-based intravenous connector in an Australian hematology-oncology
unit.
Infect Control Hosp Epidemiol.
2007;
28
610-3
Reference Ris Wihthout Link
- 13
Kellerman S, Shay D K, Howard J. et al .
Bloodstream infections in home infusion patients: the influence of race and needleless
intravascular access devices.
J Pediatr.
1996;
129
711-7
Reference Ris Wihthout Link
- 14
Kommission für Krankenhaushygiene und Infektionsprävention .
Prävention Gefäßkatheter-assoziierter Infektionen - Empfehlung der Kommission für
Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
2002;
25
907-924
Reference Ris Wihthout Link
- 15
Lee O K, Johnston L.
A systematic review for effective management of central venous catheters and catheter
sites in acute care paediatric patients.
Worldviews Evid Based Nurs.
2005;
2
4-15
Reference Ris Wihthout Link
- 16
Maragakis L L, Bradley K L, Song X. et al .
Increased catheter-related bloodstream infection rates after the introduction of a
new mechanical valve intravenous access port.
Infect Control Hosp Epidemiol.
2006;
27
67-70
Reference Ris Wihthout Link
- 17
McDonald L C, Banerjee S N, Jarvis W R.
Line-associated bloodstream infections in pediatric intensive-care-unit patients associated
with a needleless device and intermittent intravenous therapy.
Infect Control Hosp Epidemiol.
1998;
19
772-7
Reference Ris Wihthout Link
- 18
Menyhay S Z, Maki D G.
Disinfection of needleless catheter connectors and access ports with alcohol may not
prevent microbial entry: the promise of a novel antiseptic-barrier cap.
Infect Control Hosp Epidemiol.
2006;
27
23-7
Reference Ris Wihthout Link
- 19
Niel-Weise B S, Daha T J, van den Broek P J.
Is there evidence for recommending needleless closed catheter access systems in guidelines?
A systematic review of randomized controlled trials.
J Hosp Infect.
2006;
62
406-13
Reference Ris Wihthout Link
- 20
Rupp M E, Sholtz L A, Jourdan D R. et al .
Outbreak of bloodstream infection temporally associated with the use of an intravascular
needleless valve.
Clin Infect Dis.
2007;
44
1408-14
Reference Ris Wihthout Link
- 21
Russo P L, Harrington G A, Spelman D W.
Needleless intravenous systems: A review.
Am J Infect Control.
1999;
27
431-4
Reference Ris Wihthout Link
- 22
Seymour V M, Dhallu T S, Moss H A, Tebbs S E, Elliot T S.
A prospective clinical study to investigate the microbial contamination ofa needleless
connector.
J Hosp Infect.
2000;
45
165-8
Reference Ris Wihthout Link
- 23
Simon A, Bode U, Fleischhack G, Kramer M.
Surveillance of nosocomial infections in pediatric cancer patients.
Am J Infect Control.
2005;
33
611
Reference Ris Wihthout Link
- 24
Trautmann M, Moosbauer S, Schmitz F J, Lepper P M.
Experimental study on the safety of a new connecting device.
Am J Infect Control.
2004;
32
296-300
Reference Ris Wihthout Link
- 25
Widmer A, Bolliger D.
Infection risk associated with a closed luer access device.
J Hosp Infect.
2006;
63
479; author reply 479-80
Reference Ris Wihthout Link
- 26
Yebenes J C, Martnez R, Serra-Prat M. et al .
Resistance to the migration of microorganisms of a needle-free disinfectable connector.
Am J Infect Control.
2003;
31
462-4
Reference Ris Wihthout Link
- 27
Yebenes J C, Vidaur L, Serra-Prat M. et al .
Prevention of catheter-related bloodstream infection in critically ill patients using
a disinfectable, needle-free connector: a randomized controlled trial.
Am J Infect Control.
2004;
32
291-5
Reference Ris Wihthout Link
Priv.-Doz. Dr. med. Arne Simon
Oberarzt Pädiatrische Hämatologie und Onkologie, Infektiologie, Zentrum für Kinderheilkunde
der Universität
Adenauerallee 119
53113 Bonn
Phone: 0228/2873-3254/3255/3305
Fax: 0228/2873-3301
Email: asimon@ukb.uni-bonn.de